BRAF inhibitor (vemurafenib) concurrent with radiation therapy for metastatic melanoma producing severe skin and oral cavity reactions

Jonathan B. Wallach; Petra Rietschel; Shalom Kalnicki; Jana L. Fox

doi:10.1016/j.prro.2013.10.007

BRAF inhibitor (vemurafenib) concurrent with radiation therapy for metastatic melanoma producing severe skin and oral cavity reactions

Jonathan B. Wallach, Petra Rietschel, Shalom Kalnicki, Jana L. Fox

Radiation Oncology

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	e213-e216
Journal	Practical Radiation Oncology
Volume	4
Issue number	5
DOIs	https://doi.org/10.1016/j.prro.2013.10.007
State	Published - Sep 1 2014

ASJC Scopus subject areas

Oncology
Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.prro.2013.10.007

Cite this

@article{0f92dd4b6b5e4d289b4539e761b51177,

title = "BRAF inhibitor (vemurafenib) concurrent with radiation therapy for metastatic melanoma producing severe skin and oral cavity reactions",

author = "Wallach, {Jonathan B.} and Petra Rietschel and Shalom Kalnicki and Fox, {Jana L.}",

year = "2014",

month = sep,

day = "1",

doi = "10.1016/j.prro.2013.10.007",

language = "English (US)",

volume = "4",

pages = "e213--e216",

journal = "Practical Radiation Oncology",

issn = "1879-8500",

publisher = "Elsevier BV",

number = "5",

}

TY - JOUR

T1 - BRAF inhibitor (vemurafenib) concurrent with radiation therapy for metastatic melanoma producing severe skin and oral cavity reactions

AU - Wallach, Jonathan B.

AU - Rietschel, Petra

AU - Kalnicki, Shalom

AU - Fox, Jana L.

PY - 2014/9/1

Y1 - 2014/9/1

UR - http://www.scopus.com/inward/record.url?scp=84925342607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925342607&partnerID=8YFLogxK

U2 - 10.1016/j.prro.2013.10.007

DO - 10.1016/j.prro.2013.10.007

M3 - Article

C2 - 25194107

AN - SCOPUS:84925342607

SN - 1879-8500

VL - 4

SP - e213-e216

JO - Practical Radiation Oncology

JF - Practical Radiation Oncology

IS - 5

ER -

BRAF inhibitor (vemurafenib) concurrent with radiation therapy for metastatic melanoma producing severe skin and oral cavity reactions

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this